{"id":"W2159179344","doi":"10.1093/annonc/mdu141","title":"Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":604,"is_retracted":false,"has_abstract":false,"ca_institutions":"Credit Valley Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Panitumumab; KRAS; Internal medicine; Hazard ratio; Colorectal cancer; Clinical endpoint; Randomized controlled trial; Oxaliplatin; Confidence interval; Oncology; Adverse effect; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002749576,0.001799158,0.0032888,0.00033863,0.0006186562,0.001210291,0.001102072,0.001422071,0.008035826],"category_scores_gemma":[0.002376224,0.000938564,0.002956882,0.0002845508,0.00117365,0.001371698,0.0005165191,0.003804814,0.001250345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001072505,"about_ca_system_score_gemma":0.001883133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001695704,"about_ca_topic_score_gemma":0.004122618,"domain_scores_codex":[0.999313,0.0004029851,0.0000272498,0.00009682172,0.00004481991,0.0001151315],"domain_scores_gemma":[0.9987716,0.0003740763,0.0002023046,0.0001438338,0.0000934323,0.0004147273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9672286,0.003189744,0.0006070861,0.0005055342,0.001153576,0.00005465262,0.00005686395,0.0005741196,0.002738149,0.000141588,0.003407371,0.02034275],"study_design_scores_gemma":[0.9494562,0.0445363,0.002515943,0.000029931,0.0008896072,0.00005650374,0.00001795671,0.0002024006,0.0005355497,0.0002247449,0.001519316,0.00001541127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9638173,0.008861868,0.002182416,0.003325263,0.001236773,0.006244409,0.007162884,0.000498326,0.006670706],"genre_scores_gemma":[0.9604988,0.004461812,0.006116061,0.003448114,0.0008424824,0.005078377,0.0077849,0.0001751025,0.01159442],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008035826,"threshold_uncertainty_score":0.02688253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1282057758737968,"score_gpt":0.4285832052192958,"score_spread":0.300377429345499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}